Pancreatic, hepatic and biliary malignancies

Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma

Updates on triple negative breast cancer and immunotherapy

Uncommon genetic aberrations NTRK, RET, NRG

Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer

Administering systemic chemotherapy improves survival for patients with resectable CRCLM

Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma

TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemia

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared to placebo and fulvestrant

Isa-VCd induction in NDMM patients with severe renal impairment show no new safety concerns

A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM